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Although immunological unresponsiveness  to bovine serum albumin  (BSA) 1 
induced in neonatal  rabbits is relatively stable,  it can be  terminated  by injec- 
tions  of various heterologous albumins  (1,  2)  or by injections  of altered  BSA 
preparations  (3-5).  It has previously been reported  that unresponsive  rabbits 
produce lower levels of anti-BSA in response to these injections than do normal 
rabbits  similarly immunized  (1-5).  These lower levels of antibody in the pre- 
viously unresponsive  rabbits  could  be  explained  by  the  partial  inhibition  of 
termination  by  small  amounts  of  BSA  present  in  the  heterologous  albumin 
preparations.  Indeed, it has been shown that some commercial preparations  of 
albumins  are contaminated with BSA (6)  and that the simultaneous injection 
of small amounts of BSA,  along with the terminating  antigen,  suppressed  the 
production of anti-BSA (7). It is also possible that the lower levels of antibody 
in unresponsive  rabbits  immunized  with  altered  preparations  of BSA may be 
due to partial  prolongation of the unresponsive state by native determinants on 
the altered molecule, as has been indicated by the observations of Cinader et al. 
(8). The present investigation was designed to study the quantitative and quail- 
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tative response  of BSA-unresponsive rabbits free  of  significant levels of circu- 
lating BSA to injections of heterologous  albumins. 
Materials and Methods 
Rabbits.--All rabbits used in these studies were of the New Zealand white strain. 
Antigens.--Commercial  preparations of serum albumins were obtained from the following 
sources:  bovine  (BSA),  Armour  Pharmaceutical  Co.,  Chicago,  Ill.,  Lot  D71209;  human 
(HSA),  kindly supplied through the courtesy of the American Red  Cross and prepared  by 
E.  R.  Squibb  & Sons, New York, N.Y.,  Lot 591R.  Serum albumins from sheep  (SSA), pig 
(PSA), horse (ESA), and guinea pig (GPSA) were prepared from whole serum by the method 
of Schwert  (9). Albumins were trace-labeled with mI  (I*) according to the .method of Mc- 
Conahey and  Dixon  (10).  Samples were counted in  a  gamma scintillation counter with a 
sodium iodide crystal. 
Protein  Nitrogen.--Protein  nitrogen determinations were  carried  out  by a  modification 
of  the micro-Kjeldahl technique  (11)  using a  Technicon AutoAnalyzer  (Technicon Corp., 
Ardsley, N.Y.). 
Induction  of Immunological  Unresponsiveness to BSA.--Rabbits were made unresponsive 
to BSA by the injection of 100 mg during the first 24 hr of life followed by 400 mg in two 
equal doses before the 5th day of life.  This procedure has proved sufficient to make all the 
rabbits thus treated unresponsive for as long as 6 months (2). 
Termination of Unresponsiveness to BSA.--The unresponsive state to BSA was terminated 
by giving two courses of PSA, HSA, ESA, or GPSA spaced 2 wk apart. Each course consisted 
of four daily injections of 20 mg subcutaneously followed by 30 mg per kg of body weight 
intravenously on day 5.7 days after the last injection all the rabbits were bled and the sera 
tested for antibody against BSA and five cross-reacting albumins. 
Antibody  Determinations.--Precipitating  antibody  was  measured  by  the  quantitative 
method  of Talmage and Maurer  (12)  using I*  antigen and  the results are reported as aug 
antibody nitrogen (N)  per  1.0 ml of serum. Tests for binding antibody were performed by 
the ammonium sulfate technique of Farr (13)  employing 1.0 aug I* antigen N  and increasing 
dilution of  antisera, and  the  results  are  reported  as /ag I*  antigen N  bound  to the glo- 
bulin present in 1.0 ml of serum. 
Dissociation Rates.--Antibody  avidity for BSA was  measured  by a  modification of  the 
Farr ammonium sulfate technique (4, 13, 14). The antigen-binding capacity of the serum was 
determined at the same antigen concentration and temperature used in the dissociation rate 
experiments (25°C,  2.0 #g antigen N  per ml). 10 ml of each antibody solution was diluted in 
10% normal rabbit serum to a  concentration sufficient to bind 40% of the I*-antigen, and 
10 ml of this diluted antiserum was mixed  with 10 ml of I*-antigen  at a  concentration of 
2.0 aug N  per ml in lC7o normal rabbit serum. The tubes were sealed and incubated overnight 
at  25°C  to  allow  the antigen antibody interaction to  come  to  equilibrium. The next day 
duplicate 1.0 ml samples were removed from each tube (for zero time controls) and added to 
1.0 ml of ice-cold saturated ammonium sulfate. After 1 hr at 0°C the tubes were centrifuged 
and the precipitates washed with 50% saturated ammonium sulfate.  A  1000-fold  excess of 
cold antigen (in 0.5 ml) was then  added to each tube at intervals of 1 min. At intervals of 
exactly 0.5,  1.0, 1.5, 3.0,  and 6.0 hr after addition of the cold antigen, duplicate 1.0 ml samples 
were removed from each tube and added to  1.0  ml of ice-cold saturated ammonium sulfate 
and processed as were the zero time controls. Normal serum controls were included to correct 
for nonspecific precipitation. The per cent antigen I* bound at each time was calculated and 
plotted on semilogarithmic paper to determine the time (in minutes) for 50c/o of the initially 
bound antigen to dissociate from antibody (ts0). 68  IMMUNOLOGICAL UNRESPONSIVENESS  TO  BSA.  I 
RESULTS 
Binding Antibody in Sera of Normal and BSA-Unresponsive  Rabbits after In- 
jections of Various Heterologous Albumins.--Rabbits were made unresponsive to 
BSA by injection of BSA at birth. At 12 wk of age, both the unresponsive rab- 
bits  and normal rabbits  (of equivalent age and weight)  were given two  1-wk 
courses of PSA, HSA, ESA, or GPSA totalling 340 rag. These animals were bled 
7 days after the last injection of heterologous albumin and the antigen-bindlng 
capacities determined for BSA and five other albumins (cross-reactions with a 
hyperimmune anti-BSA serum ranging from 75 % for SSA to 5 % for GPSA). 
Both BSA unresponsive and normal  rabbits  produced high levels of binding 
antibody to the terminating  antigen and lower levels reactive with the other 
albumins (Table I). There were no significant differences between normal and 
unresponsive rabbits in the amount of antibody that reacted with any of the 
albumins tested. This was true regardless which heterologous albumin was used 
to terminate the unresponsive state. 63 of 68 unresponsive rabbits (91.2 %) and 
68 of 78 normal rabbits  (87.2%)  produced antibody reactive with BSA.  The 
antibody levels in the remaining 16 rabbits were low not only to the tolerated 
antigen, but to the terminating antigen and the other albumins as well. 
Precipitating Antibody in Sera of Normal and BSA-Unresponsive  Rabbits after 
Injections  of Various Heterologous Albumins.--Normal  and BSA unresponsive 
rabbits were given two 1-wk courses of immunization with various soluble serum 
albumins  and bled 7 days after the last injection.  The levels of precipitating 
antibody to BSA  and  five other albumins  were measured  using  I*  antigens. 
There were no significant differences in the amount of antibody precipitating 
with any of the albumins in sera of those normal and unresponsive rabbits which 
received either PSA or HSA (Table II). However, those normal rabbits immu- 
nized with GPSA produced greater quantities of precipitating antibody than 
did unresponsive rabbits similarly immunized. 
Inhibition  of the Termination of the Unresponsive State by the Simultaneous In- 
jeelion of the Tolerated Anligen.--The inhibition of the termination of unrespon- 
siveness by the simultaneous injection of BSA along with the terminating anti- 
gen was studied further. BSA unresponsive rabbits were given varying amounts 
of BSA simultaneously with HSA over two 1-wk courses of immunization. The 
antigen-binding capacities of the sera were determined for both BSA and HSA. 
Doses of 17.0 mg BSA or greater showed a marked inhibition of the termination 
of unresponsiveness. There was a decrease in the liter to BSA and to HSA with 
increasing amounts of BSA and only 2 of 14 rabbits receiving BSA showed an 
immune  elimination  of  a  subsequent  injection  of  the  tolerated  antigen 
(Table III). 
Dissociation Rates.--Grey (14)  has shown that the association rates of anti- 
body and antigen reactions were related to the net electrical charge of the anti- 
body molecules, while the dissociation rates were independent of charge,  and D.  C.  BENJAMIN  AND  W.  O.  WEIGLE  59 
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that therefore the dissociation rates were a more realistic measurement of avid- 
ity  of  antibody for  antigen.  Sera from  normal  and unresponsive rabbits  ob- 
tained 7 days after immunization with heterologous albumins were assayed for 
their  avidity  for  BSA  by  determining  their  dissociation  rates  with  I*-BSA. 
Table IV shows that the antibody in sera of normal rabbits immunized with 
TABLE  III 
Effect  of Simultaneous  Injection of BSA on the Termination of the 
BSA-Unresponsive  State by HSA 
BSA  Anti-BSA*  Immune eliminationS: 
rag§ 
0  10.4  9/10 
17  2.6  2/5 
170  0.2  0/4 
300  0  0/5 
* #g  antigen  N  bound  by  the  globulin  (precipitated  with  50%  saturated  ammonium 
suffate) present in 1.0 ml of serum. 
:~ Fraction of rabbits showing on immune elimination of I*-BSA. 
§ Injected simultaneously with 340 mg HSA over two  1-wk  courses of immunization. 
TABLE  IV 
Mean  Dissociation  Rates*  of Antibody from  Normal  and  BSA-Unresponsive  Rabbits  after 
Two Courses of Various  Soluble  Albumins 
Terminating antigen  Status  No. of animals  t~o* 
PSA  Unresponsive  7  6.3  4-  1.0 
Normal  11  11.2  4-  1.0 
P  0.01 
HSA  Unresponsive  10  20.4  4-  5.0 
Normal  14  42.9  4-  3.6 
P  0.01 
ESA  Unresponsive  14  74.2  -4-  8.1 
Normal  9  45.4  -4-  5.6 
P  0.02 
* Time in minutes for 50% of initially bound I*BSA to dissociate from antibody in the 
presence of  a  1000-fold  excess of  unlabeled BSA. 
PSA or HSA was more avid than antibody in sera of unresponsive rabbits simi- 
larly treated.  However, if ESA was used  to terminate  unresponsiveness,  the 
antibody in sera from  the previously unresponsive rabbits was more avid than 
that of antibody from sera of normal rabbits. 
DISCUSSION 
The data presented above indicate that the establishment of the unresponsive 
state  to BSA in neonatal rabbits does not result in death  of precursor  cells or 72  IMMUNOLOGICAL  UNRESPONSIVENESS  TO  BSA.  I 
loss of specific receptors on these cells,  suggesting that the unresponsive rabbit 
has a  cellular potential to produce antibody to BSA. Normal rabbits and rab- 
bits made unresponsive by neonatal injection of BSA made similar amounts of 
both binding and precipitating antibody to BSA after immunization with aque- 
ous preparations of BSA,  HSA,  GPSA,  or ESA.  The avidity of the  antibody 
produced  was dependent  on  the  antigen  used  to  terminate  the  unresponsive 
state and not on whether the antibody came from normal or unresponsive rab- 
bits. Thus after injection of normal and unresponsive rabbits with these heterol- 
ogous albumins, no quantitative or qualitative difference in the anti-BSA pro- 
duced  could be detected,  suggesting that  the  unresponsive rabbit had the po- 
tential to produce a normal response to the BSA-related determinants on cross- 
reacting albumins. 
It has been shown that each of the albumins used shares several determinants 
with BSA (15), and since there were few significant differences between tolerant 
and normal rabbits in  the amount of  antibody reacting  with any of the albu- 
mins, the specificity of the antibody in sera from previously unresponsive rab- 
bits may be the same as that in sera from normal rabbits similarly immunized. 
Previous reports  (1-5), however, all showed lower levels of antibody in unre- 
sponsive animals after termination of the unresponsive state with either hapten- 
substituted antigens or with certain cross-reacting antigens. The lower levels in 
those unresponsive animals immunized with hapten-substituted antigens could 
be explained by prolongation of the unresponsive state by native determinants 
on the substituted molecule very similar or identical  to those on the tolerated 
antigen. Cinader et al. (8) have shown that the injection of certain hapten-sub- 
stituted HSA preparations into HSA-unresponsive rabbits did prolong the dur- 
ation of the HSA-unresponsive state and  that  the ability to prolong this  un- 
responsive state depended on the degree of substitution.  Whether complete or 
partial inhibition was obtained depended  on the number and specificity of the 
native determinants remaining. These findings are not unexpected since it has 
been shown that  simultaneous injection  of native BSA along with the  termi- 
nating  antigen  can  suppress  the  production  of  anti-BSA  in  response  to  in- 
jections  of  heterologous  albumins.  Indeed,  very  small  amounts  of  BSA  can 
reduce  the level of anti-BSA  to  7.5%  of that formed in  control unresponsive 
rabbits,  and completely abolish the capacity of these animals to respond to a 
subsequent injection of BSA. The injection of 20 mg BSA 2 wk before, or 3.0 mg 
BSA 1 day before the start of injections of the terminating antigen has no effect 
on the production of anti-BSA. This would indicate that a certain level of BSA 
must be maintained for inhibition  to occur and  that  a  direct  competition for 
cellular  receptors  between  shared  determinants  on  BSA  and  the  terminating 
antigen is most likely responsible for this inhibition. In addition, it appears that 
the lower levels of anti-BSA reported in other studies  (1,  2)  in which  the un- 
responsive state was terminated with natural  cross-reacting antigens could be D.  C.  BENJAMIN  AND  W.  O.  WEIGLE  73 
explained by a  contamination  of the  terminating  antigen  preparations  with 
the tolerated antigen (6). In these studies, the amount of contaminating BSA 
may not have been sufficient to completely inhibit the  termination but may 
have been sufficient to reduce the amount of anti-BSA produced. In the normal 
animal, contaminating BSA would have had no inhibitory effect. 
The avidity for BSA of the antibody produced in unresponsive and normal 
rabbits seems to depend on the heterologous albumin used to terminate the un- 
responsive state.  Those unresponsive rabbits immunized with  either PSA or 
HSA produced antibody with a lower avidity for BSA than did normal rabbits 
similarly treated. However, if ESA was used as the terminating  antigen,  the 
avidity of antibody from BSA unresponsive rabbits was greater than that of 
antibody from normal rabbits. This could be explained if one assumes that there 
is a spectrum of ceils producing antibody toward a given determinant and that 
the receptors on these cells vary in their avidity for that determinant. It is pos- 
sible that in this spectrum some ceils would not be able to detect the structural 
differences (if any) between the determinants on BSA and those on the termi- 
nating antigen. Interaction between the terminating antigen and those recep- 
tors in the unresponsive animal would then have the same effect as interaction 
between these receptors and BSA (the tolerated antigen), i.e., an inhibition of 
antibody formation. When the terminating antigen was PSA or HSA, the cells 
thus  affected would be those cells producing high avidity antibody, whereas 
when ESA was the terminating antigen those cells affected would be the low 
avidity producers. The number of cells affected by any of these antigens would 
necessarily be few since quantitative differences are not seen between these un- 
responsive and normal animals. 
The presence of a normal complement of antibody-producing cells to BSA in 
rabbits rendered unresponsive to BSA by neonatal injections can most readily 
be explained if the immune response to BSA in rabbits involves the interaction 
of two cell types, both containing receptor sites for antigen, and if unresponsive- 
ness lies in a cell other than the precursor cell. That two cells are involved in the 
induction of antibody formation has been shown by several recent experiments. 
Synergistic effects have been shown between thymus and bone marrow ceils in 
the induction of an antibody response to red blood Cells (16,  17) and to human 
gamma globulin (HGG)  (18)  and that the bone marrow-derived cells are the 
precursor cells (17). It has also been shown that mice thymectomized after the 
induction of unresponsiveness escape from unresponsiveness much later than 
nonthymectomized controls (19) ; that animals injected directly into the thymus 
with antigen showed a greater degree of unresponsiveness than did animals in 
which the antigen was injected into the spleen or lymph nodes (20); and that 
specific cellular receptors may exist on both the thymus and the bone marrow- 
derived cells (21). The specificity of these receptors of the two cells interacting 
with the antigen would necessarily be different, since there does not seem to be 74  IMMUNOLOGICAL UNRESPONSIVENESS  TO  BSA.  I 
a repetition of determinants on the surface of monomeric albumins (22 and foot- 
note 2). The bone marrow cell could then carry receptors of the same specificity 
as the antibody it produces and the specificity of the thymus cell receptor may 
be toward determinants on the terminating antigen unrelated to those on BSA. 
In view of the carrier antibody theories, it appears that, in a normal rabbit, BSA 
may be presented to the antibody-forming cell by specific receptors on a  thy- 
mus-derived cell reacting with determinants of HSA unrelated to those on BSA. 
If this is the case, the BSA-unresponsive rabbit, even though it seems to possess 
a  normal complement of antibody-forming cells,  would be unable to make an 
immune response to BSA, since the thymus-derived cells would be missing. The 
presence of a  defect at only the thymus-derived cell is not  in agreement with 
observations in mice, where the defect of unresponsiveness to human ~,-globu- 
lin was shown to be at both the thymus and  bone marrow-derived cells  (21). 
However, in  the  latter  experiments  the  mice were rendered unresponsive as 
adults,  whereas in  the present experiments unresponsiveness was  induced  by 
neonatal injections. 
Other explanations for the termination of unresponsiveness have been given. 
It has been proposed that the difference between unresponsive and normal ani- 
mals is the avidity of cellular receptors for the determinants on the tolerated 
antigen and similar determinants on the terminating antigen (5,  23) with the 
avidity being much greater for the terminating antigen. If this is the case, then 
the number of cells bearing specific receptors with a great enough avidity for the 
tolerated antigen have to be too few to result in a detectable antibody response, 
whereas the number of cells responding to the cross-reacting antigen have to be 
much greater. However, the role of avidity suggested above appears unlikely, 
since the injection of relatively small amounts of the BSA simultaneously with 
large  amounts  of  the  terminating  antigen  results  in  a  marked  inhibition  of 
the termination of unresponsiveness. Bretscher and  Cohn (24)  have suggested 
that carrier antibody (either free or cell-bound) may be necessary for antibody 
formation and that the carrier antibody for the tolerated antigen is  missing in 
unresponsive animals.  This carrier antibody would necessarily be of a  special 
class, since passive anti-BSA or soluble BSA-anti-BSA complexes have no effect 
on the ability of a BSA-unresponsive rabbit to respond to BSA (2). A carrier- 
like material may still be the missing factor, but would have different properties 
than suggested by Bretscher and Cohn. 
SUMMARY 
Rabbits made unresponsive to BSA at birth were given two courses of im- 
munization with various cross-reacting albumins  at 3 months of age. Normal 
Benjamin, D.  C.,  and W.  O.  Weigle. The structural  basis for the cross-reactivity of 
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control rabbits,  of equivalent age and weight, were similarly immunized.  Sera 
obtained 7 days after the last injection were assayed for binding and precipi- 
tating antibody to six albumins and for their  avidity for BSA. No significant 
differences were found between unresponsive and normal rabbits in the amount 
of antibody reacting with any of the six albuminsused. This was the case regard- 
less which albumin was used to terminate the unresponsive state. Avidity differ- 
ences were seen and seemed to depend on the antigen used and not on the im- 
munological status of the animal. The simultaneous injection of small amounts 
of BSA inhibited  the termination  of unresponsiveness.  These results were dis- 
cussed in the light of the more recent theories of the termination of unrespon- 
siveness and of antibody formation. 
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